Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data
- 12 May 2018
- journal article
- review article
- Published by Springer Nature in Inflammopharmacology
- Vol. 26 (4) , 881-898
Abstract
Globally, low back pain (LBP) is one of the most common health problems affecting humans. The lifetime prevalence of non-specific LBP is approximately 84%, with the chronic prevalence at about 23%. Chronic LBP in humans is defined as LBP that persists for more than 12 weeks without a significant pain improvement. Although there are numerous evidence-based guidelines on the management of acute LBP, this is not the case for chronic LBP, which is regarded as particularly difficult to treat. Research aimed at discovering new drug treatments for alleviation of chronic mechanical LBP is lacking due to the paucity of knowledge on the pathobiology of this condition, despite its high morbidity in the affected adult population. For a debilitating condition such as chronic LBP, it is necessary to assess the sustained effects of pharmacotherapy of various agents spanning months to years. Although many rodent models of mechanical LBP have been developed to mimic the human condition, some of the major shortcomings of many of these models are (1) the presence of a concurrent neuropathic component that develops secondary to posterior intervertebral disc puncture, (2) severe model phenotype, and/or (3) use of behavioural endpoints that have yet to be validated for pain. Hence, there is a great, unmet need for research aimed at discovering new biological targets in rodent models of chronic mechanical LBP for use in drug discovery programs as a means to potentially produce new highly effective and well-tolerated analgesic agents to improve relief of chronic LBP. On a cautionary note, it must be borne in mind that because humans and rats display orthograde and pronograde postures, respectively, the different mechanical forces on their spines add to the difficulty in translation of promising rodent data to humans.Keywords
This publication has 140 references indexed in Scilit:
- Efficacy of classification‐based cognitive functional therapy in patients with non‐specific chronic low back pain: A randomized controlled trialEuropean journal of pain, 2012
- Pain relief produces negative reinforcement through activation of mesolimbic reward–valuation circuitryProceedings of the National Academy of Sciences, 2012
- TNF-α and IL-1β Promote a Disintegrin-like and Metalloprotease with Thrombospondin Type I Motif-5-mediated Aggrecan Degradation through Syndecan-4 in Intervertebral DiscJournal of Biological Chemistry, 2011
- Attenuation of Inflammatory Events in Human Intervertebral Disc Cells With a Tumor Necrosis Factor AntagonistSpine, 2011
- An updated overview of clinical guidelines for the management of non-specific low back pain in primary careEuropean Spine Journal, 2010
- Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actionsNature Medicine, 2010
- Pregabalin, celecoxib, and their combination for treatment of chronic low-back painJournal of Orthopaedics and Traumatology, 2009
- Repair, regenerative and supportive therapies of the annulus fibrosus: achievements and challengesEuropean Spine Journal, 2008
- Chapter 4 European guidelines for the management of chronic nonspecific low back painEuropean Spine Journal, 2006
- Acetaminophen for osteoarthritisCochrane Database of Systematic Reviews, 2006